Hester Biosciences Balance Sheet
- Market cap
- ₹1,750 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,481.18 – ₹2,777.22
As of FY25, Hester Biosciences had total assets of ₹1,138 crore and borrowings of ₹210 crore, against shareholders' equity of ₹908 crore — a debt-to-equity ratio of 0.35.
Hester Biosciences balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 788 |
| Borrowings | 210 |
| Other liabilities | 140 |
| Total liabilities | 1,138 |
| Fixed assets | 613 |
| Capital work in progress | 45 |
| Investments | 263 |
| Other assets | 263 |
| Total assets | 1,138 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹721.82
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Hester Biosciences balance sheet — frequently asked questions
What is the total debt of Hester Biosciences?
Hester Biosciences reported borrowings of ₹210 crore as of FY25.
What is Hester Biosciences' debt-to-equity ratio?
Based on the FY25 balance sheet, Hester Biosciences' debt-to-equity ratio is 0.35 — borrowings of ₹210 crore against equity capital and reserves of ₹908 crore.
What are Hester Biosciences' total assets?
Hester Biosciences' total assets were ₹1,138 crore as of FY25, including fixed assets of ₹613 crore and investments of ₹263 crore.
What is the book value per share of Hester Biosciences?
The book value per share of Hester Biosciences is ₹721.82, based on the latest reported balance sheet.
Same Data For Peers
Trade Hester Biosciences With ATS
Track HESTERBIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.